Market Tracker

12/19 11:01pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

16.78
Data as of Dec 19
 +0.64 / +3.97%
Today’s Change
5.40
Today|||52-Week Range
25.60
+127.06%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close16.14
Today’s open16.28
Day’s range15.76 - 17.28
Volume3,442,391
Average volume (3 months)1,668,432
Market cap$815.6M
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-99.95%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book7.50

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.37+2.31%
SGNTSagent Pharmaceutica...+1.95+8.07%
OMEROmeros Corp+0.87+3.91%
OREXOrexigen Therapeutic...+0.04+0.64%
Data as of 3:59pm ET, 12/19/2014

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts